Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (2021 - 2026)

DiaMedica Therapeutics filings provide 6 years of Interest Coverage Ratio readings, the most recent being 455.74 for Q1 2026.

  • Quarterly Interest Coverage Ratio rose 94.4% to 455.74 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 1597.17 through Mar 2026, up 73.67% year-over-year, with the annual reading at 3439.7 for FY2025, 3093.6% down from the prior year.
  • Interest Coverage Ratio hit 455.74 in Q1 2026 for DiaMedica Therapeutics, up from 8144.0 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.17 in Q4 2022 and bottomed at 8144.0 in Q1 2025.
  • Average Interest Coverage Ratio over 5 years is 1780.46, with a median of 302.16 recorded in 2024.
  • The largest annual shift saw Interest Coverage Ratio plummeted 2595.28% in 2025 before it skyrocketed 94.4% in 2026.
  • DiaMedica Therapeutics' Interest Coverage Ratio stood at 0.17 in 2022, then fell by 19.36% to 0.21 in 2023, then tumbled by 144773.55% to 302.16 in 2024, then plummeted by 2595.28% to 8144.0 in 2025, then surged by 94.4% to 455.74 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Interest Coverage Ratio are 455.74 (Q1 2026), 8144.0 (Q1 2025), and 302.16 (Q1 2024).